Literature DB >> 30396687

Triggering of CD99 on monocytes by a specific monoclonal antibody regulates T cell activation.

Witida Laopajon1, Supansa Pata1, Nuchjira Takheaw2, Sirirat Surinkaew3, Saichit Khummuang3, Watchara Kasinrerk4.   

Abstract

CD99, a leukocyte surface glycoprotein, has been implicated in many cellular processes including cell adhesion, cell migration and T cell activation. Our previous study demonstrated the anti-CD99 monoclonal antibody (mAb) clone MT99/3 inhibited T cell activation; however, the mechanism is unclear. In this study, we demonstrated that CD99 expressed on monocytes played a role in the inhibition of T cell activation. Anti-CD99 mAb MT99/3 downregulated the expression of costimulatory molecule CD86, but upregulated IL-6, IL-10 and TNF-α production by monocytes. The inhibitory effect of mAb MT99/3 required cell to cell contact between monocytes and lymphocytes. The soluble mediators produced by monocytes alone were insufficient to induce hypo-function of T lymphocytes. In summary, we demonstrated that ligation of CD99 on monocytes by anti-CD99 mAb MT99/3 could mediate T cell hypo-responsiveness. These findings provide the first evidence of the role of CD99 on monocytes that contributes to T cell activation.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anti-CD99 monoclonal antibody; CD99; Monocyte; T cell activation

Mesh:

Substances:

Year:  2018        PMID: 30396687     DOI: 10.1016/j.cellimm.2018.10.012

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  4 in total

1.  Three Adult Cases of STAT1 Gain-of-Function with Chronic Mucocutaneous Candidiasis Treated with JAK Inhibitors.

Authors:  Emilie W Borgström; Marie Edvinsson; Lucía P Pérez; Anna C Norlin; Sara L Enoksson; Susanne Hansen; Anders Fasth; Vanda Friman; Olle Kämpe; Robert Månsson; Hernando Y Estupiñán; Qing Wang; Tan Ziyang; Tadepally Lakshmikanth; Carl Inge E Smith; Petter Brodin; Peter Bergman
Journal:  J Clin Immunol       Date:  2022-09-02       Impact factor: 8.542

Review 2.  CD99 in malignant hematopoiesis.

Authors:  Atham Ali; Vijaya Pooja Vaikari; Houda Alachkar
Journal:  Exp Hematol       Date:  2021-12-14       Impact factor: 3.249

3.  Anti-human CD99 antibody exerts potent antitumor effects in mantle cell lymphoma.

Authors:  Nuchjira Takheaw; Gunya Sittithumcharee; Ryusho Kariya; Watchara Kasinrerk; Seiji Okada
Journal:  Cancer Immunol Immunother       Date:  2020-11-19       Impact factor: 6.968

4.  The presence of membrane bound CD99 ligands on leukocyte surface.

Authors:  Nuchjira Takheaw; Supansa Pata; Witida Laopajon; Sittiruk Roytrakul; Watchara Kasinrerk
Journal:  BMC Res Notes       Date:  2020-10-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.